美股A股
StockGist
Back
8-K2026-05-15· deepseek-chat

TIL · Instil Bio, Inc.

0001789769-26-000044

SEC filing

Summary

Instil Bio reported Q1 2026 financial results with a net loss of $4.2 million, cash position of $74.7 million, and is evaluating acquisition and in-licensing opportunities.

Key takeaways